Midatech Pharma Share Discussion Threads

[dave4545] 06/6/2022 08:21

wow lost the whole lot of gains in 15 mins this morning

scary how many people are wild gambling on spikes then taking monster losses

52314 pays 14.465p sells for 10.25p

Plenty more of them this morning

[shooter mcgavin] 02/6/2022 18:07

General share chat on telegram - Bulls/Bears welcome

hxxps://t.me/+uvhRj0z103ZjMDQ0

[petersmith6] 02/6/2022 11:09

Two day positive moments should make Monday quite interesting...and is that the sound of shorters weeping

[idiot441] 02/6/2022 07:34

Calm review includes reminders ceo webinar, broker note etc. See via tweet.

I have significant position. Will hold irrespective short term moves.

Note the volume in US! almost 10m ADR = 50m shs traded (half the shs outstanding)

Nothing to see here! Right!!!

I will attend agm

[ssrmb] 02/6/2022 07:19

US has moved from a low of 0.46 to 0.75 or +59%, that would put us over 15p for starters. Let’s see how trading in the US goes over the next few days, could be significant catching up to do by Monday ! GLA

[petersmith6] 01/6/2022 15:12

Too many people think its going to be an instant blast off to the moon. Fast track is good new but we need more updates before we can recover properly..so relax and wait

[manual dexterity] 01/6/2022 15:04

Certainly with the cash element I would categorise both MTPH and EVG as similar and very interesting in their pipeline. Both share prices have been demolished and there is some overlay between the two.

However BOTH have very interesting pipelines.



Midatech Pharma PLC (AIM:MTPH) soared 32% to 13.5p after its MTX110 treatment for recurrent glioblastoma, a form of cancer, was given fast track designation by the Food and Drug Administration.

The drug-delivery technology company said the fast track process will facilitate the development and accelerate the review of treatments for serious conditions.

"Receiving Fast Track designation for MTX110 is an important milestone for the development of the drug as it demonstrates the need for novel and effective treatment options for this currently universally fatal disease," Dmitry Zamoryakhin, chief scientific officer, said.

[manual dexterity] 01/6/2022 14:55

Indeed he is. MTPH has fallen from around the 60p levels so assuming last placing was at 28p per share to raise £10million there will be some interest around these levels.

[chesty1] 01/6/2022 14:37

Dillydally you're typing to yourself bud!

[dillydally2] 01/6/2022 14:36

Collapse imminent

[dillydally2] 01/6/2022 14:33

Dumping now at losses the impaled folks

[dillydally2] 01/6/2022 14:32

Look at the like rats running off a sinking ship

[dillydally2] 01/6/2022 14:28

Holy smokesThis is going to absolutely collapse

[dillydally2] 01/6/2022 14:25

Tops would be pumping away but he has sold

[dillydally2] 01/6/2022 14:25

Down again folks

[dillydally2] 01/6/2022 14:25

WARNINGWARNINGGANG ARE EXITINGSELL NOWSELL NOWUSA WILL DUMP IT

[dillydally2] 01/6/2022 14:22

Get out fastv

[dillydally2] 01/6/2022 14:21

Told u muppets buying at 15p

[dillydally2] 01/6/2022 14:21

Back to 10p by close

[dillydally2] 01/6/2022 14:21

Here they comeAll tumbling out at the same time Like clockwork

[dillydally2] 01/6/2022 14:15

Time to sell

[dillydally2] 01/6/2022 14:15

Buy prices now sinkingTops and the gang are getting out